| Document Date: 2014-09-09 08:21:46
Open Document File Size: 232,25 KBShare Result on Facebook
Company GW Pharmaceuticals / / Country United States / United Kingdom / / / Event FDA Phase / M&A / / Facility University of Reading / Children’s Hospital of Philadelphia / hospital Institutional Review Board / / IndustryTerm profit from products / manufacturing / chemical constituents / legalized medicinal marijuana products / / MedicalCondition treatment resistant epilepsies / treatment-resistant epilepsy / seizures / intractable epilepsy / pediatric treatment resistant epilepsies / Dravet Syndrome / seizure / improved seizure / modern epilepsy / epilepsy / Lennox Gastaut Syndrome / tiredness / treatment-resistant epilepsies / / Organization Institutional Review Board / FDA / University of Reading / NYU / Children’s Hospital of Philadelphia / Drug Enforcement Administration / / Person Russell Reynolds / Dravet Gastaut Syndromes / Drs William Gowers / Lennox Gastaut Syndromes / Lennox Gastaut / Eltayb / Ben Whalley / Orrin Devinsky / / Position physician / physician submits / / Product Epidiolex™ / CBD / / ProvinceOrState Indiana / California / Colorado / /
SocialTag |
CBD as a potential treatment for intractable epilepsy by Orrin Devinsky, MD Marijuana (Cannabis sativa and indica) is a naturally growing plant with many chemical constituents present in varying levels in the different